Latest Hydrocodone Stories

DENVER, Feb. 29, 2012 /PRNewswire/ -- Multiple studies, conducted independently by Researched Abuse, Diversion and Addiction-related Surveillance (RADARS®) System, indicate low rates of abuse, diversion and non-medical use of the pain reliever tapentadol IR since the product launched in 2009. The results of the 18-month RADARS® System study on tapentadol IR were presented at the American Academy of Pain Medicine's 28th Annual Meeting. According to the Centers for Disease Control,...

Drug companies are working to develop a prescription painkiller much more powerful than Vicodin, worrying addiction experts that it could lead to a new wave of drug abuse. With prescription painkiller abuse treatment climbing 430 percent over the past decade, addiction experts and drug control advocates are concerned that a new mega-dose of hydrocodone, the powerful ingredient found in the drugs Vicodin and OxyContin, will make things worse. The new painkiller has up to 10 times the...

MOGADORE, Ohio, Dec. 20, 2011 /PRNewswire/ -- Omega Laboratories, Inc. announced that it has become the first and only laboratory to receive 510(k) clearance from the Food and Drug Administration (FDA) for its Extended Opiates Test that detects the use of Oxycodone and Hydrocodone through human hair analysis. The clearance also included the test for Codeine, Morphine and Heroin. The ability to test for Oxycodone (eg. OxyContin® and Percocet®)* and Hydrocodone (eg. Vicodin®...

Taking even just a little too much of the pain reliever acetaminophen, the main ingredient in Tylenol, over time is more likely to be fatal than taking a single, massive overdose, British researchers warned on Tuesday. These "staggered overdoses" occur when people with ongoing pain repeatedly take slightly more acetaminophen than they should, said Dr. Kenneth Simpson of the University of Edinburgh in Scotland and lead author of the study. "They haven't taken the sort of single-moment,...

MADISON, N.J., Oct. 11, 2011 /PRNewswire/ -- American workers continue to use prescription opiates at relatively high levels, according to Drug Testing Index(TM) (DTI) data released today by Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services. Hydrocodone and oxycodones remain the most detected prescription opiates in the U.S. general workforce, with 1.3% and 1.1% positivity rates, respectively, in the first half of 2011....

New Study Reports Overdoses from Prescription Painkillers Surpass Deaths from Multiple Myeloma, Liver Disease and HIV Beverly Hills, Calif. (PRWEB) September 13, 2011 According to a report from the British Medical Journal, the number of deaths in the United States from prescription painkillers such as Vicodin, OxyContin and Suboxone, has now surpassed that of multiple myeloma, alcohol liver disease and HIV. Dr. Michael Lowenstein, who specializes in the Waismann Method, an advanced...

Boca Pharmacal, Inc., today announced that it has received approval from the FDA of its Abbreviated New Drug Application (ANDA) for Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5mg / 325mg per 5mL, the generic version of Hycet® Oral Solution distributed by FSC Laboratories, Inc. Coral Springs, Florida (PRWEB) July 21, 2011 Boca Pharmacal, Inc., today announced that it has received approval from the FDA of its Abbreviated New Drug Application (ANDA) for Hydrocodone...

HUNTSVILLE, Ala., June 24, 2011 /PRNewswire/ -- Qualitest Pharmaceuticals today issued a voluntary nationwide retail level recall of Butalbital, Acetaminophen, and Caffeine Tablets USP, 50mg/325mg/40mg, and Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5mg/500mg. This recall was initiated because an individual bottle of Butalbital, Acetaminophen, and Caffeine Tablets USP, 50mg/325mg/40mg, 500 count was found incorrectly labeled with a Hydrocodone Bitartrate and Acetaminophen...

NORTH LIBERTY, Iowa, May 24, 2011 /PRNewswire/ -- KemPharm, Inc. today announced positive results from a Phase 1 clinical trial of its most advanced opioid-based drug candidate, KP201, a novel hydrocodone prodrug for treating pain. KP201 is a new chemical entity (NCE) composed of hydrocodone chemically bound to a ligand. The data confirmed that KP201 is cleaved in man as predicted, releasing the active pharmaceutical compound hydrocodone into the bloodstream at amounts equivalent to the...

PISGAH FOREST, N.C., May 17, 2011 /PRNewswire/ -- Responding quickly to the FDA's proclaimed new limits on acetaminophen in prescription painkiller combination products, Pisgah Laboratories, Inc., http://www.pisgahlabs.com, files a patent application on abuse deterrent features for opioid drug products. Filed with the US Patent & Trademark Office (http://www.uspto.gov), this new patent application is the eighteenth filing for Pisgah and represents a substantial R&D effort directed...